Product Usage
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.
Cagrilintide (5mg) + Semaglutide (5mg) Blend
This dual-peptide weight management formulation combines Cagrilintide (an amylin analog) and Semaglutide (a GLP-1 receptor agonist) to enhance appetite suppression, fat loss, and metabolic control.
$0.00
Peptides will arrive in a lyophilized (powder) form for maximum stability
Out of stock
Buy 5 for 5% off
Buy 10 for 10% off
Buy 15 for 15% off
Cagrilintide (5mg) + Semaglutide (5mg) Blend
Overview
This dual-peptide weight management formulation combines Cagrilintide (an amylin analog) and Semaglutide (a GLP-1 receptor agonist) to enhance appetite suppression, fat loss, and metabolic control.
Key Benefits:
✔ Suppresses appetite and promotes satiety
✔ Enhances fat oxidation and weight loss
✔ Regulates blood sugar levels and insulin sensitivity
✔ Supports cardiovascular and metabolic health
Mechanism of Action:
- Cagrilintide: Mimics amylin, reducing hunger and food intake.
- Semaglutide: Activates GLP-1 receptors, slowing gastric emptying and improving insulin function.
Citations:
- Lau, J. et al. “Cagrilintide and its synergistic effects with GLP-1 receptor agonists,” Nat Metab, 2021.
- Wilding, J. et al. “Semaglutide’s role in weight management,” N Engl J Med, 2021.
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Biogenesis Peptides is a chemical supplier. Biogenesis Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Biogenesis Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.